|
|||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| |
Abstract |
|---|
|
|
|---|
Fibronectin (Fn) and tenascin (Tn) are two major extracellular matrix (ECM) glycoproteins that may have
important roles both in fibrotic lung diseases and in lung tumors. The significance of Fn and Tn in human
pleural mesothelial cells and pleural diseases is unclear. Transformed human pleural mesothelial cells
(Met5A), primary cultures of mesothelial cells, and cultured mesothelioma cell lines were investigated for
Fn and Tn immunoreactivity. Mesothelial cells were exposed for 48 to 96 h to transforming growth factor-
(TGF-
), tumor necrosis factor-
(TNF-
), amosite asbestos fibers, or oxidants (H2O2 and menadione, a compound that auto-oxidizes to produce superoxide). Immunofluorescence and Western blotting with monoclonal anti-Fn and anti-Tn antibodies, and Northern blotting with a complementary DNA
(cDNA) probe for Tn showed that mesothelial cells are capable of producing Fn and Tn. The mRNA level
and immunoreactivity of Tn was enhanced by TGF-
and TNF-
, whereas Fn was intensified only by
TGF-
. A wide range of amosite, H2O2, or menadione concentrations had no clear effect on Fn or Tn reactivity. Fn and Tn were present at low or undetectable concentrations in five of six mesothelioma cell lines,
whereas the organization of Fn immunoreactivity in these cell lines was variable. Furthermore, results obtained with the tumor tissue of these same mesothelioma patients suggested that Fn and Tn expressions do
not necessarily parallel either each other or results obtained with the cultured cells.
| |
Introduction |
|---|
|
|
|---|
The extracellular matrix (ECM) glycoproteins fibronectin
(Fn) and tenascin (Tn) are important molecules in cell adhesion and tissue repair (1). The role of Fn in cells and
tissues has been relatively well elucidated (6), whereas
the functions of Tn are less defined. Usually, the Tn level
in healthy adult tissues is low or undetectable (12). Tn is
upregulated during lung morphogenesis (13, 14), at the
sites of active growth of bronchial tubules, and in cultured
lung cells by inflammatory cytokines such as tumor necrosis factor-
(TNF-
) (15) and transforming growth factor-
(TGF-
) (16). Tn has significant antiadhesive properties, and it is known to inhibit cell adhesion to fibronectin (5). Tn has been detected in carcinomas, mainly in the
stromal tissue of the tumor (12, 17), and it may be related to the invasion capability of the tumor (22).
Highly invasive local growth and resistance to all forms
of conventional cancer treatments are typical characteristics of mesothelioma (23). Recent treatment strategies
have focused on immunotherapy and cytokine therapy,
despite poor understanding of their role in this disease (24,
25). Mesothelioma is strongly associated with many cytokines and growth factors, the most important of them being TGF-
and platelet-derived growth factor (PDGF) (23), both of which may induce the synthesis of various
adhesive and antiadhesive molecules and contribute to the
invasiveness of this tumor. No systematic comparative
studies are available on the expression and regulation of
Tn and Fn in human mesothelial cells or in human mesothelioma.
We investigated the regulation of Tn and Fn in human
mesothelial cells by exposing these cells to TGF-
, TNF-
,
oxidants, and asbestos fibers, all of which have been suggested to play roles in the pathogenesis of mesothelioma.
The transformed mesothelial cells (Met5A) that were used
in the study are simian virus 40-immortalized, nonmalignant diploid human cells with typical mesothelial morphology (26). Additional experiments were conducted on
human pleural mesothelial cells in primary culture. Tn and
Fn immunoreactivities were investigated in human mesothelioma cell-line cells established from the tumors of
mesothelioma patients.
| |
Materials and Methods |
|---|
|
|
|---|
Cells and Tissues
Cells of an immortalized human mesothelial cell line (Met-5A) (26) were provided by Dr. Curtis Harris (Laboratory of Human Carcinogenesis, National Cancer Institute, Bethesda, MD). The cells were cultured on uncoated plastic dishes, using RPMI 1640 medium supplemented with 10% heat- inactivated fetal calf serum (FCS), 0.03% L-glutamine, 100 U/ml penicillin, and 100 µg/ml streptomycin at 37°C in a 5% CO2 atmosphere. Confluent cultures were subcultured with trypsin-ethylenediaminetetraacetic acid (EDTA) (0.05%). Primary cultured mesothelial cells (passages 1 to 4) established from nonmalignant pleural cells were cultured as described earlier, using the same RPMI 1640 medium supplemented with 15% FCS. Cultured tumor cell lines were originally established from the tumor tissue of mesothelioma patients (27). The cytogenetic and histologic characterization of the cell lines (M9K, M10K, M14K, M28K, M33K, M38K) has been described previously, and a summary is shown in Table 1. The mesothelioma cells were cultured with the culture medium and under the conditions described previously (27).
|
Exposures
Cells were grown until they were subconfluent, and the medium was then changed to one that contained human recombinant TGF-
1 (1 ng/ml), TNF-
(10 ng/ml), H2O2 (10 to 50 µM), menadione (0.1 to 5 µM), amosite asbestos fibers (1 to 10 µg/cm2), or a combination of TGF-
and various concentrations of the oxidants or fibers. The concentrations of the oxidants and fibers were selected on the basis of
preliminary experiments and previously published studies
of the cytotoxicity of these fibers and oxidants in Met5A
mesothelial cells (28). Exposure times varied from 24 h
to 96 h. Two different oxidants were chosen: H2O2 is transported through the plasma membrane and consumed by intracellular antioxidant pathways, whereas menadione is a
quinone that generates superoxide intracellularly by autooxidation in the so called redox-cycling reaction.
Immunohistochemistry
Cultured mesothelial cells and mesothelioma cells were
grown on small coverslips. The plates were fixed in methanol at
20°C for 10 min, and were incubated for 30 min with
undiluted monoclonal antibodies (mAbs) for Tn (100EB2)
or Fn (52DH1). The 100EB2 antibody reacts with the two
major Tn isoforms and has been characterized earlier (20);
mAb 52DH1 recognizes extradomain A (EDA) of Fn (31).
After washing, the cells were incubated for 30 min with fluorescein isothiocyanate (FITC)-coupled sheep antimouse immunoglobulin (1:300; Jackson Immunoresearch,
West Chester, PA). Tumor biopsy specimens were examined with the alkaline phosphatase-antialkaline phosphatase (APAAP) technique as described (32). Shortly
thereafter, frozen tumor samples were cut at 6-µM thickness and the resulting sections were fixed in acetone precooled to
20°C. In the APAAP technique, incubations
with the specific antibodies were preceded by treatment
with nonimmune rabbit serum for 15 min. Sections were
incubated with primary antibody as described previously, and then incubated with rabbit antimouse antibody
(Dako, Glostrup, Denmark) for 30 min and with the
APAAP complex (Dako) for another 30 min. Immunoreactivity was visualized by exposure to a substrate solution
containing naphthol AS-BI phosphate and new fuchsin
(both from Sigma Chemical Co., St. Louis, MO), reaction
with NaNO2 (E. Merck, Darmstadt, Germany), and dilution in Tris-buffered saline, pH 8.7. The specimens were
examined with a Leitz Aristoplan microscope equipped
with appropriate filters. The relative immunoreactivity assessed independently by two investigators was expressed
as weak (+), moderate (++), or strong (+++).
Sodium Dodecyl Sulfate-Polyacrylamide Gel Electrophoresis and Western Blotting
To obtain whole-cell extracts, confluent cells were scraped into electrophoresis sample buffer. ECM constituents were isolated as described (15). The samples were boiled for 5 min and electrophoresed under reducing conditions, using 6.5% slab gels according to Laemmli (33). The amount of cell protein loaded for sodium dodecyl sulfate-polyacrylamide gel electrophoresis (SDS-PAGE) and calculated from cocultured plates was 400 µg for Tn and 100 µg for Fn. The polypeptides were transferred onto nitrocellulose sheets according to Towbin and colleagues (34). After the transfer, Tn was detected with mAb 100EB2 and EDA-Fn with mAb 52DH1. For immunostaining, peroxidase-conjugated rabbit antimouse antibody (1:200) (Dako) was used, and the polypeptides were detected by reaction with 3,3'-diaminobenzidine tetrahydrochloride (Sigma). For molecular weight standards, a high-molecular-weight kit from Sigma was used. Proteins were analyzed according to the micromethod of Bio-Rad (Hercules, CA).
Northern Blotting
Total RNA was isolated according to Chomczynski and Sacchi (35). For the analysis, polyadenosine (poly[A])-rich RNA was obtained from total RNA by using Dynabeads Oligo(dT)25 beads (Dynal, Oslo, Norway). The mRNA was denatured in the presence of 1.8 M formaldehyde, and was electrophoresed on 1.0% agarose (Agarose NA; Pharmacia, Uppsala, Sweden) in the presence of 2.1 M formaldehyde with a 1× 3-(N-morpholino) propanesulfonic acid (MOPS) running buffer at 40 V for 3 h. After electrophoresis, the gel was washed twice with 20× standard saline citrate (SSC) for 15 min, and the messenger RNA (mRNA) was transferred to a Hybond Nylon membrane (Amersham, Buckinghamshire, UK) by capillary blotting. The membrane was washed briefly with 6× SSC, air-dried for 30 min, and baked at 80°C for 2 h. Prehybridization and hybridization were conducted as described earlier. A complementary DNA (cDNA) probe covering a 2,124-bp sequence of Tn (nucleotides 793 to 2,916) was provided by professor L. Zardi (Instituto Nazionale per la Ricerca sul Cancro, Genova, Italy). The detection of the hybridized probe was conducted as described (16). The mRNA expression of Tn was compared with the glyceraldehyde-3-phosphate dehydrogenase (GAPDH) mRNA expression by scanning densitometry, using the 300A Computing Densitometer and Image Quant Software v3.0 Fast Scan (Molecular Dynamics, Sunnyvale, CA).
| |
Results |
|---|
|
|
|---|
Mesothelial Cells
Met5A cells were exposed to 1 to 10 µg/cm2 amosite, 10 to 50 µM H2O2 or to 0.1 to 5 µM menadione. Preliminary experiments conducted in duplicate indicated that 1 µg/cm2 amosite, 10 µM H2O2, and 0.1 µM menadione did not have any effects on the number of viable cells when cells were trypsinized and counted after the 48-h exposure. Amosite concentrations of 4 and 10 µg/cm2 caused 18% and 75% decreases, respectively, in the cell number of viable cells after 48 h. Corresponding decreases after exposure to 25 µM and 50 µM H2O2 were 20% and 64%, and after exposure to 1 µM and 5 µM menadione were 18% and 45%, respectively.
Immunofluorescence microscopy indicated that Met5A
cells had no significant matrix by comparison with primary
cultured mesothelial cells (not shown). Correspondingly,
Tn immunoreactivity of Met5A cells appeared in the
whole-cell extracts but not in the ECM preparations or in
immunoprecipitates from spent cultures. Immunoblotting
of the whole-cell extracts showed Tn in control Met5A
cells only when at least 400 µg protein/lane was loaded;
both Tn (280 kD and 190 kD) isoforms could be detected.
After a 48-h exposure, the Tn level was increased by
TGF-
and marginally by TNF-
(Figure 1A) but not by
the lowest oxidant concentrations (Figure 1B). Additional
experiments conducted with the other concentrations of
menadione (1 µm and 5 µM) and H2O2 (25 µm and 50 µM),
and with the three concentrations of the fibers, showed no
induction of Tn in any case. Exposure of the cells to the
combination of TGF-
(1 ng/ml) and the three concentrations of the oxidants or fibers showed no difference in Tn
immunoreactivity as compared with the effect of TGF-
alone (data not shown). Northern blotting revealed that
both Tn transcripts (6 kb and 8 kb) were upregulated by
TGF-
and TNF-
, and very marginally by amosite fibers
(Figure 2).
|
|
Fn immunoreactive polypeptides were found in the
whole-cell extracts and in the precipitates from the culture
medium. The characteristic 240-kD band of Fn was intensified by TGF-
but not by TNF-
(Figure 3A) or by the
nontoxic oxidant concentrations (Figure 3B). Higher concentrations of H2O2 (Figure 4) but not of menadione (Figure 5) caused slight increases in Fn immunoreactivity.
|
|
|
Asbestos fibers (4 µg/cm2 and 10 µg/cm2, 48 h) caused
slight decreases in Fn immunoreactivity, possibly because
of the toxicity of the fibers. Similarly, Fn levels were decreased in the cells exposed to the combination of TGF-
and the fibers (10 µg/cm2), as compared with exposure to
TGF-
alone (Figure 6). Given that Fn has been shown to
be induced by asbestos fibers (4 µg/cm2) in rat pleural mesothelial cells during 72- to 96-h exposure (36, 37), additional experiments were also conducted, in which Met5A
cells were exposed to amosite asbestos fibers (4 µg/cm2)
for 96 h. However, in accord with the findings in our previous study (30), this dose and duration of exposure caused a
50% loss in cell viability. Furthermore, this exposure decreased Fn immunoreactivity when standardized against
the cell protein (not shown). Because the 4 µg/cm2 dose of
asbestos was toxic to these cells, further experiments were
conducted in which the cells were exposed for 72 h to a
nontoxic (1 µg/cm2) dose of the fibers. No change in Fn or
Tn reactivity was observed (Figure 7).
|
|
Because Met5A cells are transformed cells, and do not
present detectable ECM, experiments were also conducted
on primary-cultured human pleural mesothelial cells. These
results showed positive Tn immunoreactivity in the ECM
and also in the culture medium precipitates. The results
with the matrix preparations of primary-cultured cells confirmed the induction of Tn with TGF-
but not with the nontoxic concentrations of asbestos fibers or H2O2 (Figure
8A). Experiments with the primary-cultured cells also confirmed the induction of Fn by TGF-
(Figure 8B).
|
Mesothelioma Cell Lines
Western blotting experiments showed that Fn was prominently expressed in M33K mesothelioma cells but not in the other mesothelioma cell lines examined in the study (M9K, M14K, M38K) (Figure 9). Tn could be detected only in M9K mesothelioma cells (Figure 9). In addition to the cell lines shown in Figure 9, two further cell lines (M10K, M28K) had weak Fn expression and were negative for Tn (not shown).
|
Immunofluorescence microscopy indicated that all mesothelioma cell lines were positive for Fn, but the pattern of Fn immunofluorescence varied, with M33K cells presenting an intense extracellular Fn network, whereas Fn was intracellularly localized in M9K and M38K cells (Figure 10). Tn immunoreactivity was undetectable in M33K cells and very low in M9K cells and M38K cells.
|
Because the cell culture itself may have effects on protein expression, and ECM proteins may be excreted not only by tumor cells but also by adjacent nonmalignant cells, immunostaining was also done, using tissues from tumor material obtained at autopsy of these same patients. No constant pattern could be observed: Tn and Fn immunofluorescence were highly variable. This variation was observed especially with Tn; Fn reactivity was moderate or abundant in five of six cases (Table 2). Tn and Fn immunoreactivity varied in different areas of the same biopsy, and both intracellular and stromal Tn and Fn immunoreactivity could be detected.
|
| |
Discussion |
|---|
|
|
|---|
This study showed that human pleural mesothelial cells
are capable of producing low levels of Fn and Tn. Both
glycoproteins were induced by TGF-
, and Tn was also
marginally induced by TNF-
and Fn by H2O2. Immunofluorescence microscopy of the mesothelioma cell-line cells
used in the study showed low Fn and Tn immunoreactivities in most cases. In agreement with the findings in previous studies (18, 38), these results suggest that the low immunoreactivity of these glycoproteins in cultured cells
might not reflect the situation in vivo.
Tn appears to be upregulated in fibrosing alveolitis (39,
40), and it may be involved in the pathogenesis of fibrotic pleural diseases as well. We have recently detected Tn in
cultured human bronchial epithelial cells (15, 16), and
other researchers have suggested that Tn is produced by
alveolar epithelial cells (39). In the present study TGF-
and TNF-
increased Tn immunoreactivity in Met5A mesothelial cells. Northern blotting showed that both 8.0-kb
and 6.0-kb transcripts of Tn were increased, indicating transcriptional regulatory control or prolongation of the
half-life of the mRNA for Tn. The observed regulation of
Tn is in agreement with the findings in our earlier studies
with bronchial epithelial cells (15, 16), and with the finding
of enhanced Tn expression in chick embryo fibroblasts in
response to TGF-
(41). Tn expression appears to be tightly
regulated in a cell-type-specific manner (42), and this is
the first study to show that TGF-
is a potent inducer of
Tn in human pleural mesothelial cells.
Although the regulation of Fn in various cells and tissues is elucidated relatively well, and rat pleural mesothelial cells have been shown to produce Fn (36, 37, 43, 44), no systematic studies are available on the regulation of Fn in human mesothelial cells. Our results with human mesothelial cells contradict earlier findings, because Kuwara and coworkers (36, 37) found that crocidolite and chrysotile asbestos fibers (4 µg/cm2) induced prominent Fn release into the conditioned media of rat mesothelial cells during 72 to 96 h exposure. In our study, neither 1 µg (nontoxic) nor 4 µg (toxic) doses of amosite caused any increase in Fn or Tn immunoreactivity in Met5A mesothelial cells. The discrepancy between these results may be related to different species, the immortalized cell line used in our study, a different fiber type, or fiber toxicity. Our results do not exclude Fn or Tn induction by chronic asbestos exposure, but they suggest that growth factors and inflammatory cytokines are more important than oxidants or fibers in causing Fn and Tn induction in human mesothelial cells.
Tn expression has not been investigated previously in
human mesothelioma. TGF-
, which is a potent inducer of
Tn in vitro, is one potential cytokine involved in the pathogenesis of mesothelioma. Furthermore, TGF-
contributes
not only to the pathogenesis but possibly also to the aggressive growth of this tumor (25, 45). The TGF-
level
in healthy lungs and airways is low, whereas this cytokine
is strongly expressed in pulmonary fibrosis, and present at
high levels in malignancies, one of the latter being mesothelioma (47). It has also been suggested that Tn accumulation in malignant neoplasms can be caused by
growth factors, such as TGF-
, and may be associated with
the invasiveness of the tumor (22). We found that Tn was
negative in most mesothelioma cell lines but was induced
by TGF-
both in transformed Met5A mesothelial cells and in primary-cultured human mesothelial cells. Given
that cultured tumor cells may secrete much lower amounts
of Tn than the tumor cells in vivo, and that Tn may be produced by nonmalignant cells in the close vicinity of mesothelium, we also assessed Tn expression in tumor tissues
obtained at autopsy from the same patients from whom
the cultured mesothelioma cells had come. The data showed a high variation of Tn in these tumor tissues, but also in
different areas of one tumor-tissue specimen. These results also suggested that downregulation of Tn may not be
a universal response to cell culture, because Tn was detected in one mesothelial cell line (M9K) by Western-blot
analysis, whereas Tn immunostaining of the corresponding
tissue was very weak. It has to be emphasized, however, that autopsy material does not represent ideal material
with which to investigate the expression of these proteins
in malignant tumor.
The significance of Fn and its immunohistochemical pattern in human mesothelioma cells is unknown. Fn expression and organization can be changed during neoplastic conversion to mesothelioma in rat lungs (44, 50). In our study, M33K mesothelioma cells showed intense and M9K mesothelioma cells showed low Fn reactivity. Also, the organization of Fn immunoreactivity in M33K cells differed from that in the other cell lines, because these cells contained high levels of Fn in their ECM, whereas in M9K mesothelioma cells Fn was intracellularly localized. The significance of this finding remains unclear. Three histologic subtypes of mesothelioma can be identified: epithelioid, sarcomatoid, and mixed type. Both M33K and M9K mesothelioma cells represented the mixed histologic subtype. Recently, Ferriola and colleagues (44) have shown that the organization of Fn fibrils can be heterogenous in rat pleural mesothelioma cells, and it has been suggested that ECM components such as Fn may contribute to the invasive behavior of mesothelioma (44, 50).
In summary, human pleural mesothelial cells produce
Fn and Tn, the production of which can be modulated in
vitro by TGF-
. The expression of both of these glycoproteins in cultured mesothelial and mesothelioma cells was
low in most cases, but did not necessarily parallel either
each other or their expression in autopsy material. More
studies are needed to investigate further the role of these glycoproteins in human mesothelium and mesothelioma in
vivo.
| |
Footnotes |
|---|
Address correspondence to: Vuokko Kinnula, M.D., Ph.D., Department of Internal Medicine, University of Oulu, Kajaanintie 50, FIN-90220 Oulu, Finland. E-mail: vuokko.kinnula{at}oulu.fi
(Received in original form December 30, 1996 and in revised form December 15, 1997).
Acknowledgments: This study was partly supported by Finland's Antituberculosis Association Foundation (V.K.) and by the Medical Faculty of the University of Helsinki (I.V.). The skillful technical assistance of Ms. Marja-Leena Piiroinen is acknowledged.
Abbreviations
ECM, extracellular matrix;
Fn, fibronectin;
GAPDH, glyceraldehyde-3-phosphate dehydrogenase;
SDS-PAGE, sodium dodecyl sulfate-polyacrylamide gel electrophoresis;
SSC, standard saline citrate;
TGF-
, transforming growth factor-
;
Tn, tenascin;
TNF-
, tumor necrosis factor-
.
| |
References |
|---|
|
|
|---|
1. Chiquet-Ehrismann, R., E. J. Mackie, C. A. Pearson, and T. Sakakura. 1986. Tenascin: an extracellular matrix protein involved in tissue interactions during fetal development and oncogenesis. Cell 47: 131-139 [Medline].
2. McGowan, S.. 1992. Extracellular matrix and the regulation of lung development and repair. FASEB J. 6: 2895-2904 [Abstract].
3. Kovacs, E., and L. DiPietro. 1994. Fibrogenic cytokines and connective tissue production. FASEB J 8: 854-861 [Abstract].
4. Raghow, R.. 1994. The role of extracellular matrix in post-inflammatory wound healing and fibrosis. FASEB J. 8: 823-831 [Abstract].
5. Chiquet-Ehrismann, R.. 1990. What distinguishes tenascin from fibronectin? FASEB J 4: 2598-2604 [Abstract].
6. Dean, D. C.. 1989. Expression of the fibronectin gene. Am. J. Respir. Cell Mol. Biol. 1: 5-10 .
7. Ruoslahti, E.. 1989. Fibronectin and its receptors. Annu. Rev. Biochem. 57: 375-413 [Medline].
8. Hynes, R. O. 1981. Fibronectin and its relation to cellular structure and behavior. In Cell Biology of the Extracellular Matrix, Vol. 76. E. Hay, editor. Plenum Press, New York. 181-189.
9. Rennard, S. I., and R. G. Crystal. 1981. Fibronectin in human bronchopulmonary lavage fluid. J. Clin. Invest. 69: 113-122 .
10. Romberger, D. J., J. D. Beckmann, L. Claassen, R. F. Ertl, and S. I. Rennard. 1992. Modulation of fibronectin production of bovine bronchial epithelial cells by transforming growth factor-beta. Am. J. Respir. Cell Mol. Biol 7: 149-155 .
11.
Roman, J.,
E. Crouch,
K. Pickles, and
J. McDonald.
1989.
Regulation of fibronectin biosynthesis by dexamethasone, transforming growth factor-beta and cAMP in human cell lines.
J. Cell Biol.
106:
2159-2217
12. Koukoulis, G. K., V. E. Gould, A. Bhattacharyya, J. E. Gould, A. A. Howeedy, and I. Virtanen. 1991. Tenascin in normal, reactive, hyperplastic, and neoplastic tissues. Hum. Pathol. 22: 636-643 [Medline].
13. Young, S., L. Y. Chang, and H. E. Erickson. 1994. Tenascin-C in rat lung: distribution, ontogenity and role in branching morphogenesis. Dev. Biol. 161: 615-625 [Medline].
14. Zhao, Y., and S. L. Young. 1995. Tenascin in rat lung development: in situ localization and cellular sources. Am. J. Physiol. 13: L482-L491 .
15. Härkönen, E., I. Virtanen, A. Linnala, L. L. Laitinen, and V. L. Kinnula. 1995. Modulation of fibronectin and tenascin production in human bronchial epithelial cells by inflammatory cytokines in vitro. Am. J. Respir. Cell Mol. Biol 13: 109-115 [Abstract].
16.
Linnala, A.,
V. Kinnula,
L. A. Laitinen,
V. Lehto, and
I. Virtanen.
1995.
Transforming growth factor-
regulates the expression of fibronectin and
tenascin in BEAS 2B human bronchial epithelial cells.
Am. J. Respir. Cell
Mol. Biol
13:
578-585
[Abstract].
17. Lightner, V. A., J. R. Marks, and S. S. McCachren. 1994. Epithelial cells are an important source of tenascin in normal and malignant human breast tissue. Exp. Cell Res. 210: 177-181 [Medline].
18. Hiraiwa, N., K. Hirokatsu, T. Sakakura, and M. Kusakabe. 1993. Induction of tenascin in cancer cells by interactions with embryonic mesenchyme mediated by a diffusible factor. J. Cell Sci 104: 289-296 [Abstract].
19. Howeedy, A. A., I. Virtanen, L. Laitinen, N. S. Gould, G. K. Kokoulis, and V. E. Gould. 1990. Differential distribution of tenascin in the normal, hyperplastic and neoplastic breast. Lab. Invest. 6: 798-806 .
20. Tiitta, O., T. Wahlström, I. Virtanen, and V. E. Gould. 1993. Tenascin in inflammatory conditions and neoplasms of the urinary bladder. Virchows Arch. B Cell Pathol. 63: 283-287 [Medline].
21. Soini, Y., P. Pääkkö, K. Nuorva, D. Kamel, A. Linnala, I. Virtanen, and V.-P. Lehto. 1993. Tenascin immunoreactivity in lung tumors. Am. J. Clin. Pathol 100: 145-150 [Medline].
22. Jahkola, T., T. Toivonen, K. Von Smitten, C. Blomqvist, and I. Virtanen. 1997. Expression of tenascin invasion border of early breast cancer correlates with higher risk of distant metastasis. Int. J. Cancer (In press)
23. Jaurand, M. C., J. Bignon, and P. Brochard, editors. 1993. International conference on mesothelial cell and mesothelioma: past, present and future. Eur. Respir. Rev. 3.
24. Garlepp, M. J., and C. C. Leong. 1995. Biological and immunological aspects of malignant mesothelioma. Eur. Respir. J. 8: 643-650 [Abstract].
25. Fitzpatrick, D. R., D. J. Peroni, and H. Bielefeldt-Ohmann. 1995. The role of growth factors and cytokines in the tumorigenesis and immunobiology of malignant mesothelioma. Am. J. Respir. Cell Mol. Biol 12: 455-460 [Abstract].
26. Ke, Y., R. R. Reddel, B. I. Gerwin, H. K. Reddel, A. N .A. Somers, M. G. McMenamin, M. A. LaVeck, R. A. Stahel, J. F. Lechner, and C. C. Harris. 1989. Establishment of a human in vitro mesothelial cell model system for investigating mechanisms of asbestos-induced mesothelioma. Am. J. Pathol. 134:979-991.
27.
Pelin-Enlund, K.,
K. Husgafvel-Pursiainen,
L. Tammilehto,
M. Klockars,
K. Jantunen,
B. I. Gerwin,
C. C. Harris,
T. Tuomi,
E. Vanhala,
K. Mattson, and
K. Linnainmaa.
1990.
Asbestos-related malignant mesothelioma: growth,
cytology, tumorigenicity and consistent chromosome findings in cell lines
from five patients.
Carcinogenesis
11:
673-681
28. Kinnula, V. L., K. Aalto, K. O. Raivio, S. Walles, and K. Linnainmaa. 1994. Cytotoxcity of oxidants and asbestos fibers in cultured human mesothelial cells. Free Radic. Biol. Med. 16: 169-176 [Medline].
29. Kinnula, V. L., K. O. Raivio, A. Ekman, and M. Klockars. 1995. Neutrophil and asbestos fiber-induced cytotoxicity in cultured human mesothelial and bronchial epithelial cells. Free Radic. Biol. Med. 18: 391-399 [Medline].
30. Pelin, K., K. Husgafvel-Pursiainen, M. Vallas, E. Vanhala, and K. Linnainmaa. 1992. Cytotoxicity and anaphase aberrations induced by mineral fibers in cultured human mesothelial cells. Toxicology In Vitro 5: 445-450 .
31.
Vartio, T.,
L. Laitinen,
O. Närvänen,
M. Cutolo,
L.-E. Thornell,
L. Zardi, and
I. Virtanen.
1987.
Differential expression of the ED sequence-containing form of cellular fibronectin in embryonic and adult human tissues.
J.
Cell Sci
88:
419-430
32.
Tani, T.,
T. Karttunen,
T. Kiviluoto,
E. Kivilaakso,
R. E. Burgeson,
P. Sipponen, and
I. Virtanen.
1996.
6
4 Integrin and newly deposited laminin-1
and laminin-5 form the adhesion mechanism of gastric carcinoma.
Am. J. Pathol.
149:
781-793
[Abstract].
33. Laemmli, U. K.. 1970. Cleavage of structural proteins during the assembly of the head of the bacteriophage T4. Nature 227: 680-685 [Medline].
34.
Towbin, H.,
T. Staehelin, and
J. Gordon.
1979.
Electrophoretic transfer of
proteins from polyacrylamide gels to nitrocellulose sheets. Procedure and
some applications.
Proc. Natl. Acad. Sci. USA
76:
4350-4354
35. Chomczynski, P., and N. Sacchi. 1987. Single-step method of RNA isolation by acid guanidinium thiocyanate-phenol-chloroform extraction. Anal. Biochem 162: 156-159 [Medline].
36. Kuwahara, M., M. Kuwahara, K. E. Bijwaard, D. M. Gersten, C. A. Diglio, and E. Kagan. 1991. Mesothelial cells produce a chemoattractant for lung fibroblasts: role of fibronectin. Am. J. Respir. Cell Mol. Biol 5: 256-264 .
37. Kuwahara, M., M. Kuwahara, K. Verma, T. Ando, D. R. Hemenway, and E. Kagan. 1994. Asbestos exposure stimulates pleural mesothelial cells to secrete the fibroblast chemoattractant fibronectin. Am. J. Respir. Cell Mol. Biol 10: 167-176 [Abstract].
38. Lightner, V. A., J .R. Marks, and S. S. McCachren. 1994. Epithelial cells are an important source of tenascin in normal and malignant human breast tissue. Exp. Cell Res. 210:177-184.
39. Kaarteenaho-Wiik, R., T. Tani, R. Sormunen, Y. Soini, I. Virtanen, and P. Pääkkö. 1996. Tenascin immunoreactivity as a prognostic marker in usual interstitial pneumonia. Am. J. Respir. Crit. Care Med. 154: 511-518 [Abstract].
40. Wallace, W. A. H., S. E . M. Howie, D. Lamb and D. M. Salter. 1995. Tenascin immunoreactivity in cryptogenic fibrosing alveolitis. J. Pathol. 175: 415-420.
41.
Pearson, C. A.,
D. Pearson,
S. Shibahara,
J. Hofsteenge, and
R. Chiquet-Ehrismann.
1988.
Tenascin: cDNA cloning and induction by TGF-
.
EMBO J
10:
2677-2981
.
42. Rettig, J. W., H. P. Erickson, A. P. Albino, and P. Garin-Chesa. 1994. Induction of human tenascin (Neuronectin) by growth factors and cytokines: cell type-specific signals and signalling pathways. J. Cell Sci. 107: 487-497 [Abstract].
43. Rennard, S. I., M.-C. Jaurand, J. Bignon, O. Kawanami, V. J. Ferrans, J. Davidson, and R. G. Crystal. 1984. Role of pleural mesothelial cells in the production of the submesothelial connective tissue matrix of lung. Am. Rev. Respir. Dis 130: 267-274 [Medline].
44.
Ferriola, P., and
W. Stewart.
1996.
Fibronectin expression and organization
in mesothelial and mesothelioma cells.
Am. J. Physiol
271:
L804-L812
45. Upham, J. W., M. J. Garlepp, A. W. Musk, and B. W. S. Robinson. 1995. Malignant mesothelioma: new insights into tumour biology and immunology as a basis for new treatment approaches. Thorax 50: 887-893 [Medline].
46.
Schwarz, L.,
J. A. Wright,
M.-C. Gingras,
P. Kondaiah,
D. Danielpour,
M. Pimentel,
M. B. Sporn, and
A. H. Greenberg.
1990.
Aberrant TGF-
production and regulation in metastatic malignancy.
Growth Factors
3:
115-127
[Medline].
47. Border, W. A., and E. Ruoslahti. 1992. Transforming growth factor in disease: the dark side of tissue repair. J. Clin. Invest 90: 1-7 .
48. Roberts, A. B., and M. B. Sporn. 1993. Physiological actions and clinical applications of transforming growth factor. Growth Factors 8: 1-9 [Medline].
49. Maeda, J., N. Ueki, T. Ohkawa, N. Iwahashi, T. Nakano, T. Hada, and K. Higashino. 1994. Transforming growth factor-beta 1- and beta 2-like activities in malignant pleural effusions caused by malignant mesothelioma or primary lung cancer. Clin. Exp. Immunol 98: 319-322 [Medline].
50.
Klominek, J.,
K. H. Robert, and
K. G. Sundqvist.
1993.
Chemotaxis and
haptotaxis of human malignant mesothelioma cells: effects of fibronectin,
laminin, type IV collagen, and an autocrine motility factor-like substance.
Cancer Res
53:
4376-4382
This article has been cited by other articles:
![]() |
C. R. Kunz, M. R. Jadus, G. D. Kukes, F. Kramer, V. N. Nguyen, and S. A. Sasse Intrapleural Injection of Transforming Growth Factor-{beta} Antibody Inhibits Pleural Fibrosis in Empyema Chest, November 1, 2004; 126(5): 1636 - 1644. [Abstract] [Full Text] [PDF] |
||||
![]() |
R. KaarteenahoWiik, E. Lakari, Y. Soini, R. Pöllänen, V. L. Kinnula, and P. Pääkkö Tenascin Expression and Distribution in Pleural Inflammatory and Fibrotic Diseases J. Histochem. Cytochem., September 1, 2000; 48(9): 1257 - 1268. [Abstract] [Full Text] |
||||
![]() |
P. PAAKKO, R. KAARTEENAHO-WIIK, R. POLLANEN, and Y. SOINI Tenascin mRNA Expression at the Foci of Recent Injury in Usual Interstitial Pneumonia Am. J. Respir. Crit. Care Med., March 1, 2000; 161(3): 967 - 972. [Abstract] [Full Text] [PDF] |
||||
![]() |
H. I. Pass, B. W. Robinson, J. R. Testa, and M. Carbone Emerging Translational Therapies for Mesothelioma* Chest, December 1, 1999; 116(suppl_3): 455S - 460S. [Abstract] [Full Text] [PDF] |
||||
| ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |
| Proc. Am. Thorac. Soc. | Am. J. Respir. Crit. Care Med. |